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Metabolism is integral to the pathogenicity of Candida
albicans, a major fungal pathogen of humans. As well as
providing the platform for nutrient assimilation and
growth in diverse host niches, metabolic adaptation
affects the susceptibility of C. albicans to host-imposed
stresses and antifungal drugs, the expression of key viru-
lence factors, and fungal vulnerability to innate immune
defences. These effects, which are driven by complex
regulatory networks linking metabolism, morphogene-
sis, stress adaptation, and cell wall remodelling, influence
commensalism and infection. Therefore, current concepts
of Candida–host interactions must be extended to include
the impact of metabolic adaptation upon pathogenicity
and immunogenicity.
Adaptation of Candida albicans to the host
Fungal pathogens are driven by the need to assimilate
nutrients, survive, and multiply. In the short term this
requires the flexibility to adapt to environmental change.
In the long term this has depended on the evolution of
mechanisms that permit this flexibility. The outcome for
the host, although being of importance to that individual, is
of secondary importance to the fungal pathogen. Following
dissemination to a new host, a fungal cell attempts to
assimilate local nutrients, counter any local environmental
stresses, and, if possible, evade any local host defences.
Recent data indicate that these adaptive processes are
inextricably linked. In other words, the ability of a fungal
cell to counter environmental stresses and host defences is
strongly influenced by its metabolic and physiological sta-
tus, and hence by local nutrient availability, reinforcing
the truism ‘you are what you eat’. Consequently, infection
outcome depends on the physiological robustness of the
fungal pathogen within host niches as well as on the
efficacy of host defences in these niches.
The major fungal pathogen, Candida albicans, is an
opportunistic pathogen that is obligately associated with
warm-blooded animals [1]. C. albicans normally thrives as
a relatively harmless commensal organism in the micro-
biota of the skin, the oral cavity, and the gastrointestinal
(GI) and urogenital tracts of most healthy individuals [1,2].
However, C. albicans infection can be triggered by pertur-
bations of the normal microbiota (e.g., by antibiotic treat-
ments), breaks in GI–blood barriers (e.g., as a result of
injury or surgery), or by the use of medical implants (upon
which C. albicans can form elaborate biofilms that seed
bloodstream infection) [3]. Moreover, individuals with com-
promised immune defences suffer the greatest risk of
C. albicans infection. For example, HIV/AIDS patients
are highly susceptible to oral thrush, and neutropenic
patients or individuals with heritable disorders in immune
signalling are highly susceptible to life-threatening system-
ic C. albicans infections of the blood and internal organs
[3,4]. In addition, the risk of infection is increased in diabetic
patients and in those receiving parenteral nutrition [3]. In
the context of this review, these observations highlight two
important points. First, C. albicans adapts effectively to a
diverse range of host niches, including nutrient availability
in these niches. Second, the probability of infection is strong-
ly influenced by the potency of the innate immune system.
We argue that these factors are interrelated.
We review here current knowledge about the metabolic
adaptation of C. albicans during commensalism and infec-
tion. We focus primarily on carbon source because of the
pivotal role of central carbon metabolism, and because
more is known about this aspect of metabolism. However,
nitrogen, oxygen, phosphorus, sulphur, and micronutrient
assimilation are also crucial for C. albicans pathogenicity,
and many of the principles we discuss in the context of
carbon are relevant to these processes. We suggest that the
pivotal importance of metabolic adaptation to colonisation
and disease progression extends well beyond the exploita-
tion of available nutrients for efficient energy-generation
and biomass production, and affects colonisation and dis-
ease progression at multiple levels.
Metabolism: the platform for C. albicans pathogenicity
The development of powerful cellular, immunological, mo-
lecular, and genomic tools has empowered rapid advances
in our understanding of C. albicans pathobiology, elevating
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this fungus to the status of a model fungal pathogen. For
some time it has been clear that a defined set of virulence
factors promote C. albicans pathogenicity, including
yeast–hypha morphogenesis, phenotypic switching, adhe-
sins, invasins, and secreted hydrolases [1,2]. More recently
the application of unbiased genome-wide screens has
reminded us that multifarious fitness attributes are also
crucial to C. albicans pathogenicity. These include the
metabolic capacity to assimilate the host nutrients that
support cell division, the resistance to physiologically rel-
evant stresses imposed in host microenvironments, the
tolerance to the elevated temperatures of the host, and
the construction of a robust cell wall [5–9]. Metabolism
provides the platform upon which all other fitness attri-
butes depend, generating the precursors and energy re-
quired for cell wall biosynthesis, antioxidant production,
macromolecular repair, and protein refolding, for example.
The essentiality of metabolism means that fungal specific
pathways, or key enzymes with fungal specific catalytic
mechanisms, represent potential targets for antifungal
drug therapies [10,11].
C. albicans cells display efficient metabolic adaptation
to host microenvironments, rapidly tuning their metabo-
lism to the available nutrients. These microenvironments
are complex, dynamic, and often glucose-limited. For ex-
ample, glucose levels are maintained at around 0.06–0.1%
(3–5 mM) in the bloodstream, and are around 0.5% in
vaginal secretions [12,13]. Consequently, the expression
of key metabolic functions is controlled in a niche-specific
fashion during host colonisation, commensalism, and dis-
ease progression [12,14,15] (Table 1). C. albicans cells
induce glycolytic, tricarboxylic acid cycle, and fatty acid
b-oxidation genes during mucosal invasion [16,17]. In the
bloodstream and during renal infection, C. albicans popu-
lations are heterogeneous, individual cells displaying gly-
colytic activity (hexose catabolism) or gluconeogenic
activity (hexose anabolism), depending upon their imme-
diate microenvironments [12,18,19]. Following phagocyto-
sis by macrophages and neutrophils, C. albicans cells
display expression patterns that reflect carbon starvation,
activating enzymes involved in fatty acid b-oxidation, the
glyoxylate cycle, and gluconeogenesis [19–21]. Lactic acid
metabolism is essential for GI colonisation [22], and this
non-fermentable carboxylic acid is present at significant
concentrations in the vagina (0.4%: 45 mM) [13]. There-
fore, C. albicans cells thrive in host microenvironments
that contain contrasting carbon sources.
Metabolic adaptation is controlled by complex transcrip-
tional networks in C. albicans [9,23,24]. The cellular roles
of some of these networks have been conserved during
yeast evolution, such as the general control of amino acid
metabolism (GCN response) [9,25] and sugar-sensing path-
ways [26]. Interestingly, the regulation of central carbon
metabolism has undergone major transcriptional rewiring
in C. albicans relative to Saccharomyces cerevisiae. For
example, glycolysis is induced by Gcr1 in S. cerevisiae, but
by Gal4 and Tye7 in C. albicans [9,23,24].
The importance of metabolic adaptation for GI coloni-
sation and systemic infection has been highlighted by the
elaboration of regulatory networks that are required for
these processes in C. albicans. In vivo genetic screens have
indicated that Tye7 (a glycolytic activator) is specifically
required for GI colonisation, whereas Rtg1/3 and Hms1
(which modulate hexose catabolism) promote both GI col-
onisation and systemic infection [27]. Metabolic adaptation
within host niches is linked in part to the morphological
states of the fungus in these niches, such as yeast, pseu-
dohyphal, and hyphal cells, white and opaque cells, and the
recently described GUT (‘Gastrointestinally-indUced
Transition’) phenotype [28–30]. Nevertheless, metabolic
adaptation is integral to C. albicans commensalism and
pathogenicity.
Carbon adaptation modulates stress resistance
Metabolism also promotes the virulence of C. albicans
indirectly by enhancing stress adaptation. Stress resis-
tance is required for C. albicans virulence: it increases
the survival of fungal cells in host niches by reducing their
vulnerability to local environmental stresses and to phago-
cytic killing [5,31,32]. Metabolism contributes to stress
adaptation by generating molecules such as the osmolyte
glycerol, antioxidants such as glutathione, and the stress
Table 1. Candida albicans carbon metabolism in host niches
Gene regulationa
Host niche Glycolysis Gluconeogenesis Glyoxylate cycle Fatty acid
b-oxidation
Refs
Blood plasma [19]
Neutrophils [12,17,19,21,56]; Mette Jacobsen, PhD thesis,
Aberdeen University, 2005
Macrophages [12,20]; Mette Jacobsen, PhD thesis,
Aberdeen University, 2005
Oral mucosa [16,17]
Kidneyb / / / / [12], Mette Jacobsen, PhD thesis,
Aberdeen University, 2005
Liverc [17,58]
aUpregulation (red arrows), downregulation (blue arrows), and no significant regulation (grey arrows) are expressed relative to the control C. albicans cells used in each
transcript profiling experiment. Upregulation or downregulation is inferred on the availability of data for some (not all) of the genes on these pathways. These expression
patterns display temporal regulation.
bPopulation heterogeneity in the expression patterns is observed by single cell profiling, presumably because of variability in the availability of host carbon sources
between immediate cellular microenvironments and the local consumption of these carbon sources by the invading fungus.
cThe upregulation of genes involved in both hexose catabolism and anabolism in these transcript profiling experiments could be due to the population heterogeneity of C.
albicans cells colonising the liver.
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protectant trehalose [5]. Therefore, the ability of C. albi-
cans cells to respond to environmental stress is likely to
depend upon the preadapted metabolic state of these cells,
and hence upon available nutrients in host microenviron-
ments. Almost without exception, however, the analysis of
C. albicans stress responses has been performed on cells
cultured on rich, glucose-containing media [5] that differ
significantly from host microenvironments which are often
glucose-limited (above). Significantly, recent data indicate
that changes in carbon source exert dramatic effects upon
the stress resistance of C. albicans [33,34].
Transient exposure to glucose induces the transcription
of C. albicans genes involved in oxidative stress adapta-
tion, thereby enhancing cellular resistance to acute oxida-
tive stress [34]. This phenomenon, which is regulated by
glucose-sensing pathways, probably reflects adaptive pre-
diction [35] whereby C. albicans has ‘learnt’ over evolu-
tionary time to anticipate phagocytic attack following
entry to the bloodstream [8]. Interestingly, the contrasting
evolutionary pressures experienced by C. albicans and its
relatively benign cousin S. cerevisiae have yielded con-
trasting predictive stress responses to glucose. Glucose
enhances oxidative stress resistance in C. albicans, where-
as it decreases stress resistance in S. cerevisiae via protein
kinase A (PKA)-mediated repression of the core transcrip-
tional response to stress [36,37]. The differing effects of
glucose in these yeasts are largely due to the functional
rewiring of Msn2/4 transcription factors, which activate
this core stress response in S. cerevisiae and Candida
glabrata [37,38], but control weak acid stress responses
in C. albicans [39].
Carbon adaptation also affects resistance to osmotic
stress and antifungal drugs [33,40]. These effects, which
are mediated partly through PKA signalling [41], may relate
to the effects of metabolic adaptation upon the cellular
abundances of osmolytes such as glycerol, and antioxidants
such as glutathione and trehalose [34,42,43]. Glycerol and
trehalose are synthesised via short metabolic branches off
the glycolytic pathway. However, these effects also involve
C. albicans cell wall remodelling [33,40]. Growth on differ-
ent carbon sources yields C. albicans cells with cell walls
that differ architecturally and biophysically (below). These
preadapted cell walls confer cells with differing abilities to
survive the imposition of osmotic and cell wall stresses. For
example, compared with cells grown on glucose, lactate-
grown cells display increased resistance to osmotic stress,
amphotericin B, and caspofungin, and reduced resistance to
an azole antifungal drug [33]. These alterations, which have
been observed for a range of carbon sources including other
sugars (fructose and galactose), other carboxylic acids (py-
ruvate), lipids, and amino acids [33], correlate with carbon
source-mediated changes in the cell wall proteome [40].
These studies suggest that the metabolic adaptation of C.
albicans cells to local nutrients within host niches influences
their ability to rebut local environmental stresses and resist
antifungal drug therapy.
Carbon adaptation triggers cell wall remodelling
Changes in carbon source exert dramatic effects on the C.
albicans cell wall [33]. The cell wall has a characteristic
architecture comprising a relatively thick inner lattice of b-
glucan and chitin that is decorated with a dense coat of
mannan fibrils (Figure 1) [6,44]. These mannans represent
heavily N- and O-glycosylated proteins, many of which are
covalently crosslinked to the carbohydrate infrastructure
[45,46]. This structure has been defined for C. albicans cells
grown on glucose. The relative proportions of b-glucan,
chitin, and mannan are similar for glucose- and lactate-
grown cells. However, cell wall biomass is significantly
reduced after growth on lactate, and the cell walls of lac-
tate-grown cells possess a b-glucan and chitin layer that is
half the thickness of that for glucose-grown cells (Figure 1)
[33]. The dynamics of these changes, which have not been
described, probably depend upon the construction of new cell
wall. Furthermore, significant changes were observed in the
cell wall proteome [40]. Significantly, the levels of many cell
wall remodelling enzymes were affected by carbon source,
including glucanosyltransferases (Pga4, Phr1, and Phr2),
glucosyltransferases (Bgl1), and transglycosylases (Crh11).
Therefore, changes in crosslinking between cell wall biopo-
lymers no doubt contribute to the altered biophysical prop-
erties of lactate-grown cell walls, which are more porous,
more hydrophobic, and less elastic than those of glucose-
grown cells [33].
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Figure 1. Changes in carbon source programme major changes in cell wall architecture. Transmission electron micrographs of the Candida albicans cell wall from cells
grown on lactate or glucose as sole carbon source are shown on the left [33]. The cartoon on the right illustrates the structure of the C. albicans cell wall (adapted, with
permission, from [76]).
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The mechanisms by which carbon source influences C.
albicans cell wall structure remain obscure, but are likely to
involve a combination of metabolism and signalling. Nu-
merous links probably exist between the complex regulatory
networks that control sugar sensing (which include AMP
kinase and adenylyl cyclase–PKA signalling) and cell wall
biosynthesis and remodelling in C. albicans (which involve
PKC, calcineurin, and stress signalling) [6,26]. In addition,
carbon fluxes into cell wall macromolecules must differ
significantly during growth on sugars and on secondary
carbon sources such as lactate because the generation of
hexoses required for b-glucan, mannan, and chitin synthesis
via gluconeogenesis is an energy-demanding process. Irre-
spective of the mechanisms by which they occur, the effects
of carbon source upon cell wall architecture that have been
defined in vitro are likely to be highly relevant to host niches
because changes in cell wall structure take place following
cultivation in blood and under vaginal simulating conditions
[47,48]. Therefore, local carbon sources in host niches must
have a strong influence on the architecture and functionality
of the C. albicans cell wall.
Metabolic adaptation influences virulence factors
In addition to enhancing stress resistance and promoting
cell wall remodelling, there are longstanding reports show-
ing that metabolic adaptation influences the pathogenicity
of C. albicans by modulating the expression of key viru-
lence factors (Figure 2). For example, glucose is one of
several stimuli that can trigger hyphal morphogenesis,
and glycolytic genes are induced during this yeast-to-hy-
pha transition [49,50]. In addition, metabolic genes ac-
count for approximately one-third of genes that are
regulated during the white–opaque phenotypic switch:
white cells upregulate glycolytic genes whereas opaque
cells upregulate genes involved in respiratory metabolism
[29]. The expression of secreted aspartic proteinase (SAP)
genes is regulated in response to available nitrogen and
carbon sources [51]. For example, SAP2 is expressed at
high levels during growth on glycerol, at medium levels on
glucose or galactose, and at low levels when C. albicans
cells are grown on ethanol [51]. Furthermore, growth on
different dietary sugars strongly influences the adhesion of
C. albicans to abiotic and host surfaces [52,53], and also
biofilm formation [54].
Therefore it is not surprising that key metabolic func-
tions are regulated alongside other fitness attributes and
virulence factors in a niche-specific fashion during host
colonisation, commensalism, and disease progression
[14,15]. For example, following exposure to macrophages
or neutrophils, C. albicans induces genes required for the
assimilation of secondary carbon sources and amino acid
biosynthesis alongside genes involved in oxidative stress
Host nutrients
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Figure 2. Nutrients influence the expression of key virulence factors in Candida albicans. Nutrient adaptation influences the expression of secreted aspartic proteases
(SAPs), yeast–hypha morphogenesis, adhesion, and biofilm formation via an integrated network of metabolic and virulence signalling pathways. The images of white and
opaque cells are from Zordan et al. [61], and the image of C. albicans adhesion is from Delgado-Silva et al. [100]. The SAP crystal structure is reproduced, with permission,
from Cutfield et al. [101], and the biofilm images from Nobile et al. [72].
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adaptation (SOD1, CAT1, and GPA3), hyphal growth
(ECE1), and adhesion (HWP1) [12,20,21,55,56]. This cor-
egulation of fitness and virulence is also observed during
GI colonisation, mucosal invasion, and systemic infection
[16,17,28,57,58].
Metabolic adaptation appears to be coordinated actively
with the regulation of key virulence factors via complex
signalling networks. For example, the adenylyl cyclase–
PKA–Efg1 signalling axis controls carbon metabolism (in
part via Tye7) as well as yeast–hypha morphogenesis,
white–opaque phenotypic switching, and stress resistance
[41,59–62]. The TOR (‘target of rapamycin’)–Nrg1 and
Gcn2–Gcn4 signalling axes regulate metabolism as well
as filamentous growth [8,9,25,63–65]. These intercon-
nected regulatory networks contribute differentially to
host colonisation and infection because the inactivation
of Efg1 attenuates systemic infection but promotes GI
colonisation [57,66]. The view that metabolism actively
modulates other C. albicans virulence attributes is rein-
forced by at least two additional observations. First, muta-
tions that disrupt key aspects of metabolism also affect cell
wall integrity, stress sensitivity, virulence factors, and
pathogenicity [12,28,67–72]. Second, regulatory networks
that are required for GI colonisation or systemic infection
include metabolic components [27].
The impact of metabolism upon the expression of viru-
lence factors can be indirect, involving longer-term tem-
poral relationships that highlight the dynamic nature of
local niches. The stimulation of yeast-to-hypha morpho-
genesis via amino acid catabolism provides an excellent
example of this [73]. In the absence of glucose, C. albicans
cells exploit amino acids as a carbon source, excreting the
excess nitrogen in the form of ammonia. This raises the
ambient pH of the local environment, thereby triggering
hyphal development [73]. It is conceivable that this phe-
nomenon might help to protect C. albicans cells against
macrophage killing by inhibiting acidification of the pha-
golysosome, as well as promoting morphogenesis in other
host niches [74].
Carbon adaptation modulates immune surveillance
Metabolic adaptation also influences C. albicans pathoge-
nicity at a further level – by modulating immune surveil-
lance. Phagocytic cells (primarily macrophages and
neutrophils) play a key role in preventing C. albicans infec-
tion [75]. These innate immune cells attempt to recognise C.
albicans cells initially via pattern recognition receptors
(PRRs) that detect specific pathogen-associated molecular
patterns (PAMPs) on the fungal cell surface. Fungal b-
glucan is detected through Dectin-1, and mannans via
TLR4, Dectin-2, DC-SIGN, MINCLE, and macrophage man-
nose receptor 1 [75,76]. These initial PAMP–PRR interac-
tions activate phagocyte intracellular signalling pathways,
for example via the Dectin-1/SYK/CARD9 and TLR4/TRIF–
MYD88 pathways. This triggers induction of antimicrobial
effector mechanisms such as the respiratory burst, as well as
the release of a variety of proinflammatory cytokines, che-
mokines, and lipids that stimulate other leukocytes and
attract them to the site of infection [75].
Following phagocytosis, a skirmish ensues between the
C. albicans cell and the phagocyte. The fungal cell is
trapped within the phagosome, which then undergoes
maturation and lysosomal fusion to create the phagolyso-
some [77]. During this process the phagocyte attempts to
kill the fungal cell by exposing it to a combination of
reactive oxygen and nitrogen species, protease activation,
potassium fluxes, and decreased ambient pH [75,78,79].
Meanwhile, C. albicans attempts to respond by activating
oxidative stress responses and by forming hyphae that are
capable of rupturing and killing the phagocyte [78,80,81].
The outcome of the battle between fungus and host,
which depends upon numerous individual skirmishes, has
a major impact upon disease outcome. In general, in
healthy individuals invading C. albicans cells are cleared
effectively by innate immune defences. By contrast, the
balance can be tipped towards the development of poten-
tially lethal systemic infections by factors that attenuate
phagocytic potency (such as immunosuppression or herita-
ble defects in phagocytic signalling pathways [75]) or that
promote fungal colonisation (such as antibacterial thera-
pies or biofilm formation on implanted medical devices [2]).
Therefore, growth conditions that increase the physiologi-
cal robustness of the fungus may tip the balance, reducing
phagocytic efficacy.
The metabolic environment at the site of infection affects
the interaction between the fungus and the immune cells. C.
albicans cells grown on lactate are less visible to the immune
system than cells grown on glucose (Figure 3) [82]. Com-
pared with glucose-grown cells, lactate-grown C. albicans
cells stimulate the production of more interleukin-10 (IL-10)
and less IL-17 by human peripheral blood mononuclear cells
from healthy volunteers. This trend is observed for a range
of clinical C. albicans isolates from different epidemiological
clades and from different host niches [82]. Lactate-grown
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Figure 3. Changes in carbon source impact on immune surveillance by altering the
recognition of Candida albicans cells by innate immune cells and by reducing the
susceptibility of the fungal cells to phagocytic killing via elevated oxidative stress
resistance [8].
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C. albicans cells are also phagocytosed less efficiently by
murine macrophages. Furthermore, those lactate-grown C.
albicans cells that are engulfed by the macrophages are
better able to kill and escape from macrophages (Figure 3).
These observations suggest that growth on a non-ferment-
able secondary carbon source renders C. albicans cells less
visible to the immune system, and less easy to kill than
glucose-grown cells. Therefore, the mechanistic basis for the
reduced immune visibility of lactate-grown C. albicans cells
probably lies in the cell wall because many of the key PAMPs
involved in immune recognition are located in the cell wall,
and changes in cell wall structural components are known to
affect immune recognition [48,81,83–85]. However, these
changes in immune visibility do not simply relate to the
altered fluxes to cell wall biosynthesis during growth on
glucose or lactate because C. albicans cells grown on a
mixture of glucose plus lactate possess thick cell walls
[33] but even so invoke similar immune responses to lac-
tate-grown cells [82].
Additional observations link metabolic adaptation with
cell wall structure and immune recognition. For example,
C. albicans opaque cells differ from white cells with respect
to their metabolism, cell surface properties, and immuno-
genicity [86]. Furthermore, these properties are mechanis-
tically linked by well-defined mutations that affect white–
opaque switching, metabolism, and host interactions
[59,61,62]. C. albicans scavenges the micronutrients zinc
via the pH-regulated antigen Pra1 [87] and ferritin iron via
the hypha-specific cell wall adhesin Als3 [88]. Hyphal
development and hypoxia involve metabolic adaptation,
changes to the cell wall, and changes in immune recogni-
tion [47,76,81]. Furthermore, differences in the Dectin-1-
mediated clearance of C. albicans cells during systemic
infection have been shown to relate to the differential
activation of cell wall biosynthetic functions in vivo within
renal microenvironments [89].
Recent data indicate that local microenvironments with-
in host niches also affect the metabolism and functionality of
innate immune cells, and subsequently their interaction
with C. albicans. A crucial role was recently proposed for
glucose metabolism in the activation of immune cells.
Whereas naı¨ve and resting cells metabolise glucose mainly
via oxidative phosphorylation, a switch to aerobic glycolysis
(also termed the ‘Warburg effect’) is crucial for proliferating
lymphocytes [90], and subsequently for important anti-Can-
dida mechanisms such as the deployment of a T helper 17
(Th17) response [91]. Moreover, recent studies have shown
that glycolysis and succinate play key roles in modulating
the capacity of the innate immune system to mount a proper
inflammatory response [92]. The important impact of glu-
cose metabolism upon immune function leads to the hypoth-
esis that it also modulates antifungal host defence. This
hypothesis, which needs further study, has been recently
strengthened by the observation that in epithelial cells
mTOR (a key regulator that integrates nutrient inputs
and energy levels to control cell growth and proliferation)
is central for protection against C. albicans-induced cell
damage [93]. Another example of metabolic modulation of
immune responses is provided by endogenous tryptophan
catabolism in the GI mucosa, which promotes IL-22 produc-
tion by innate lymphoid cells, which in turn enhances
intestinal immunity and protection against C. albicans
[94]. Therefore, the local metabolic environment of the host
contributes, together with the metabolic adaptation of C.
albicans, to the efficacy or failure of local immune surveil-
lance mechanisms.
Concluding remarks and future perspectives
To summarise, metabolic adaptation impacts upon C. albi-
cans pathogenicity at multiple levels: by promoting nutri-
ent assimilation, cell wall remodelling, stress resistance,
and the expression of virulence factors, and also by influ-
encing immune surveillance (Figure 4). In addition, meta-
bolic adaptation affects antifungal drug susceptibility
[33,40]. Consequently, preadaptation to different growth
conditions affects the virulence of C. albicans cells during
systemic and mucosal infection [33,95], as well as the
ability to clear these infections with antifungal drugs
[96]. We reason, therefore, that during infection C. albicans
cells growing in host niches with differing nutrient avail-
abilities will display differing degrees of stress resistance
and virulence, will vary with respect to their vulnerability
to innate immune defences, and will differ with respect to
their susceptibility to antifungal therapy.
Numerous challenges lie ahead (Box 1). It will be impor-
tant to define the mechanistic links that connect metabolic
adaptation with stress resistance, with drug susceptibility,
and with innate immune recognition and killing. As well as
being important for our understanding of C. albicans patho-
biology, these mechanistic links could conceivably provide
therapeutic approaches that might augment the activities
of current antifungal drugs. For example, compounds
that block nutrient-enhanced antifungal drug resistance,
glucose-enhanced oxidative stress resistance, or carbon-in-
duced cell wall remodelling would increase the susceptibili-
ty of C. albicans to antifungal therapy and/or host immune
defences. In this respect it is important to note that
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Figure 4. Nutrient adaptation affects Candida albicans pathogenicity at multiple
levels. Nutrient adaptation contributes directly to pathogenicity by supporting
fungal growth. Nutrient adaptation also promotes pathogenicity indirectly through
cell wall remodelling, by enhancing stress resistance, by modulating the
expression of key virulence factors, and by affecting the efficacy of immune
surveillance by innate immune cells (see text).
Review Trends in Microbiology November 2014, Vol. 22, No. 11
619
rapamycin, as an inhibitor of TOR and glucose-sensing, was
initially developed as a novel antimycotic drug [97]. Unfor-
tunately, its immunosuppressive effects (through the con-
comitant inhibition of mTOR in immune cells), has
precluded its full development for treatment of human
fungal diseases. Identification of specific inhibitors for the
fungal TOR has the potential to represent an important
therapeutic avenue.
It will be particularly challenging to characterise the
links between metabolism, stress and drug resistance,
virulence, and immune surveillance in the context of infec-
tion. Host niches are complex and dynamic. Local nutrient
availability changes constantly during colonisation and
disease progression as the fungus assimilates host nutri-
ents, and the host responds to the fungus [98]. Individual
host niches display considerable spatial as well as tempo-
ral heterogeneity which, in combination with the stochas-
ticity of gene expression, contribute to the population
heterogeneity of C. albicans cells within host niches
[12,55]. Therefore, in addition to powerful genome-wide
screens and expression profiling [16,17,27,57,58,71,72],
new experimental approaches must be exploited to define
the spatial and temporal behaviours of individual cells and
lesions within infected tissues. These might involve, for
example, 2D elemental, molecular, and luminescent imag-
ing of lesions and tissues during infection with well-defined
C. albicans strains and mutants [12,55,98,99]. When com-
bined with the local dissection of immunological responses
to fungal infection, these approaches will provide invalu-
able insights into fungus–host interactions during coloni-
sation and infection. Meanwhile, we argue that current
perceptions of Candida–host interactions must incorporate
the influences of metabolic adaptation upon pathogenicity
and immunogenicity.
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